REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • September 13th, 2016 • Venaxis, Inc. • In vitro & in vivo diagnostic substances • Colorado
THIS REGISTRATION RIGHTS AGREEMENT (this "Agreement") is made as of September 12, 2016, by and among Venaxis, Inc., a Colorado corporation (the "Company"), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an "Investor."
FORM OF LOCK-UP AGREEMENTLock-Up Agreement • September 13th, 2016 • Venaxis, Inc. • In vitro & in vivo diagnostic substances • Colorado
This LOCK-UP AGREEMENT, as may be amended, supplemented or modified from time to time in accordance with the terms hereof, is made as of September 12, 2016 (this "Agreement") by and between Venaxis, Inc., a Colorado corporation (the "Company"), and the Investor executing this Agreement (the "Investor").
STOCK PURCHASE AGREEMENTStock Purchase Agreement • September 13th, 2016 • Venaxis, Inc. • In vitro & in vivo diagnostic substances • Colorado
THIS STOCK PURCHASE AGREEMENT (this "Agreement") is made and entered into as of September 12, 2016, by and among the selling stockholders of BiOptix Diagnostics, Inc. set forth on Schedule A to this Agreement and executing this Agreement (each, a "Seller" and collectively, the "Sellers"), BiOptix Diagnostics, Inc., a Delaware corporation (the "Company"), Venaxis, Inc., a Colorado corporation ("Venaxis"), Venaxis Sub Inc., a Delaware corporation and wholly-owned subsidiary of Venaxis (the "Purchaser"), and, for purposes of Article 7 only, Remeditex Ventures, LLC (the "Sellers' Representative"). Each of the Sellers, the Company, Venaxis and the Purchaser are sometimes referred to in this Agreement as a "Party" and are collectively referred to in this Agreement as the "Parties" to this Agreement. Certain capitalized terms are defined in Section 9.12.
